Therapeutic Asset Ratings

8,399 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Beta-Thalassemia Major	Paul Szabolcs	P1/2	CCC (52)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Cancer	Regeneron Pharmaceuticals	P1/2	CCC (52)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Cervical Cancer	OncoNano Medicine, Inc.	P1/2	CCC (52)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Gastroesophageal Junction Adenocarcinoma	Palleon Pharmaceuticals, Inc.	P1/2	CCC (52)
Indocyanine Green Neoplasm	University of Pennsylvania	P1/2	CCC (52)
Inno-206 B-Cell Chronic Lymphocytic Leukemia	AstraZeneca	P1/2	CCC (52)
Iodixanol Biopsy Proven Non Small Cell Lung Cancer	Radboud University Medical Center	P1/2	CCC (52)
Ipilimumab Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8	National Cancer Institute (NCI)	P1/2	CCC (52)
Ipilimumab Malignant Pleural Mesothelioma	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)
Ipilimumab Skin Basal Cell Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (52)
Irinotecan Pediatric Solid Tumor	St. Jude Children's Research Hospital	P1/2	CCC (52)
Irinotecan Uterine Cancer	Genmab	P1/2	CCC (52)
JAB 3312 Colorectal Cancer	Allist Pharmaceuticals, Inc.	P1/2	CCC (52)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells HIV Infectious Disease	AIDS Malignancy Consortium	P1/2	CCC (52)
LENVATINIB Disease Related To Transplantation	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P1/2	CCC (52)
LIDOCAINE Memory Disorders in Old Age	University of Dublin, Trinity College	P1/2	CCC (52)
LIDOCAINE Amnestic Disorder	University of Dublin, Trinity College	P1/2	CCC (52)
LIDOCAINE Neuropathic Chronic Pain	Pontificia Universidad Catolica de Chile	P1/2	CCC (52)
lp-118 Acute Lymphoblastic Leukemia	University of Chicago	P1/2	CCC (52)
L-Valine, S-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenonyl-2-(aminomethyl)-4-thiazolecarbonyl-2-methylalanyl-, (5?2)-lactone, benzenesulfonate (1:1) NRAS Gene Mutation	OnKure, Inc.	P1/2	CCC (52)
m3814 Advanced Solid Tumors	Telix Pharmaceuticals (Innovations) Pty Limited	P1/2	CCC (52)
MAT2A-IN-9 MTAP-null Solid Tumors	Amgen	P1/2	CCC (52)
Mb-Cart20.1 Non-Hodgkin Lymphoma	Miltenyi Biomedicine GmbH	P1/2	CCC (52)
Mebufotenin Anxiety State	Biomind Labs Inc.	P1/2	CCC (52)
Mebufotenin Depression Anxiety Disorder	Biomind Labs Inc.	P1/2	CCC (52)

Showing 601 to 625 of 8,399 assets

PreviousPage 25 of 336Next